Meejeon Roh

  • 618 Citations

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Understanding prostate cancer using molecular biology approaches in combination with transgenic mouse model has been the main focus of my independent and collaborative research. I have an extensive expertise in mouse models as well as molecular characteristics of cancer cells. My ultimate research goal is to translate what we have learned in the laboratory setting into clinically relevant therapy, which is evidenced by my grant supports oriented to translational research. Recently, I have been working with Dr. Schaeffer to understand the molecular alterations behind the racial disparity of African American men in prostate cancer, specifically the role of VGLL3, a newly identified novel racial disparity modulator in prostate cancer. Our focus is to investigate its role and underlying molecular mechanism as well as its value as a biomarker in prostate cancer using various cancer cell models. I am well-qualified to perform this proposal based on extensive molecular biology and translational research experience and collaboration expertise.

Education/Academic qualification

PhD, University of Alabama at Birmingham

… → 2001

Fingerprint Dive into the research topics where Meejeon Roh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


NADC Pilot

Agulnik, M., Roh, M. & Song, C.

National Cancer Institute


Project: Research project

  • Research Output

    • 618 Citations
    • 18 Article
    • 1 Comment/debate

    Modeling African American prostate adenocarcinoma by inducing defined genetic alterations in organoids

    Unno, K., Roh, M., Yoo, Y. A., Al-Shraideh, Y., Wang, L., Nonn, L. & Abdulkadir, S. A., Feb 7 2017, In : Oncotarget. 8, 31, p. 51264-51276 13 p.

    Research output: Contribution to journalArticle

  • 8 Scopus citations

    Bmi1 marks distinct castration-resistant luminal progenitor cells competent for prostate regeneration and tumour initiation

    Yoo, Y. A., Roh, M., Naseem, A. F., Lysy, B., Desouki, M. M., Unno, K. & Abdulkadir, S. A., Oct 5 2016, In : Nature communications. 7, 12943.

    Research output: Contribution to journalArticle

  • 27 Scopus citations

    SIRT2-mediated deacetylation and tetramerization of pyruvate kinase directs glycolysis and tumor growth

    Park, S. H., Ozden, O., Liu, G., Song, H. Y., Zhu, Y., Yan, Y., Zou, X., Kang, H. J., Jiang, H., Principe, D. R., Cha, Y. I., Roh, M., Vassilopoulos, A. & Gius, D., Jul 1 2016, In : Cancer Research. 76, 13, p. 3802-3812 11 p.

    Research output: Contribution to journalArticle

  • 36 Scopus citations

    RNAi screen identifies a synthetic lethal interaction between PIM1 overexpression and PLK1 inhibition

    Van Der Meer, R., Song, H. Y., Park, S. H., Abdulkadir, S. A. & Roh, M., Jun 15 2014, In : Clinical Cancer Research. 20, 12, p. 3211-3221 11 p.

    Research output: Contribution to journalArticle

  • 16 Scopus citations

    A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53

    Kim, J., Roh, M., Doubinskaia, I., Algarroba, G. N., Eltoum, I. E. A. & Abdulkadir, S. A., Jan 19 2012, In : Oncogene. 31, 3, p. 322-332 11 p.

    Research output: Contribution to journalArticle

  • 34 Scopus citations